Who
Chirag K. Patel
President & Co-CEO
Company insider
Files Form 4 as: President & Co-CEO, Amneal Pharmaceuticals.
In numbers
- Trades disclosed
- 58
- Buys
- 6
- Sells
- 0
- Bought
- $1.9M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 May 2018
- Last trade
- 10 Aug 2026
- Last filed
- 12 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 12 Aug 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,381,734 | filing |
| 10 Aug 2026filed 12 Aug 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,381,734 | filing |
| 4 Mar 2026filed 5 Mar 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —92,593 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —92,593 | filing |
| 4 Mar 2026filed 5 Mar 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $503K37,825 at $13.30 | filing |
| 4 Mar 2026filed 5 Mar 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —92,593 | filing |
| 4 Mar 2026filed 5 Mar 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $503K37,825 at $13.30 | filing |
| 4 Mar 2026filed 5 Mar 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —92,593 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —59,931 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $208K15,616 at $13.31 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —733,944 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —59,931 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —733,944 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $4.0M297,537 at $13.31 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —59,931 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —733,944 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —59,931 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $208K15,616 at $13.31 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —733,944 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $4.0M297,537 at $13.31 | filing |
News
No headline names them, or the companies they trade most, lately.